Discussed in this episode:
- The CDC’s Advisory Committee on Immunization Practices (ACIP) met last week, and advised making the new vaccine for Respiratory Syncytial Virus (RSV) available to a broader swath of people. RSV is very deadly in infants, and quite dangerous to elderly people, but data presented at ACIP’s meeting suggested it’s of benefit to high-risk people as young as 50. If the CDC Director adopts the recommendation, that means health insurance will start paying for the RSV vaccine in those age cohorts. Currently, however, the CDC has no Director.
- Tuberculosis rates are rising just as the US is pulling out of international efforts to treat, and thereby reduce the spread of, the disease.
To send us a question in advance of next week’s show, write to: coronacalls@kpfa.org
Tune in live Monday mornings at 7:30am Pacific at kpfa.org.
Podcast music credit: Now Son by Podington Bear, licensed under a Attribution-NonCommercial 3.0 International License.